Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Franco, D. A.
Right arrow Articles by Greenberg, H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Franco, D. A.
Right arrow Articles by Greenberg, H. S.
Related Collections
Right arrow All Immunology
Right arrow All Oncology
Right arrow Chemotherapy-tumor
Right arrow Acute disseminated encephalomyelitis

5-FU multifocal inflammatory leukoencephalopathy and dihydropyrimidine dehydrogenase deficiency

David A. Franco, MD; and Harry S. Greenberg, MD

From the Department of Neurology, University of Michigan Medical Center, Ann Arbor.



View larger version (98K):

[in a new window]
  		Figure 1. MRI on October 10, 1998, showing two fluid attenuated inversion recovery images (A, B) with multiple high-signal white matter lesions.

 


View larger version (106K):

[in a new window]
  		Figure 2. T1-weighted MRI after gadolinium administration with several enhancing lesions on October 10, 1998 (A) and a reduction in the number of enhancing lesions by December 16, 1998 (B).

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by AAN Enterprises, Inc.